Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Susan Shih Huang, M.D.

Co-Author

This page shows the publications co-authored by Susan Huang and Jonathan Finkelstein.
Connection Strength

3.292
  1. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011 Apr 18; 29(18):3398-412.
    View in: PubMed
    Score: 0.463
  2. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009 Jul; 124(1):e1-11.
    View in: PubMed
    Score: 0.411
  3. Parental knowledge about antibiotic use: results of a cluster-randomized, multicommunity intervention. Pediatrics. 2007 Apr; 119(4):698-706.
    View in: PubMed
    Score: 0.352
  4. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005 Sep; 116(3):e408-13.
    View in: PubMed
    Score: 0.315
  5. Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period. Pediatrics. 2017 Nov; 140(5).
    View in: PubMed
    Score: 0.182
  6. Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis. Antimicrob Resist Infect Control. 2014; 3:16.
    View in: PubMed
    Score: 0.144
  7. Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts. J Pediatric Infect Dis Soc. 2014 Mar; 3(1):23-32.
    View in: PubMed
    Score: 0.138
  8. Trends in antibiotic use in Massachusetts children, 2000-2009. Pediatrics. 2012 Jul; 130(1):15-22.
    View in: PubMed
    Score: 0.126
  9. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis. 2012 May 15; 205(10):1589-92.
    View in: PubMed
    Score: 0.124
  10. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012 Mar; 31(3):249-54.
    View in: PubMed
    Score: 0.124
  11. New approaches to estimating national rates of invasive pneumococcal disease. Am J Epidemiol. 2011 Jul 15; 174(2):234-42.
    View in: PubMed
    Score: 0.117
  12. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J. 2011 Apr; 30(4):302-8.
    View in: PubMed
    Score: 0.116
  13. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009 Jul 11; 9:110.
    View in: PubMed
    Score: 0.103
  14. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008 Jan; 121(1):e15-23.
    View in: PubMed
    Score: 0.093
  15. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis. 2007 Feb 01; 195(3):347-52.
    View in: PubMed
    Score: 0.086
  16. Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis. 2005 May 01; 40(9):1215-22.
    View in: PubMed
    Score: 0.076
  17. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004 Nov; 114(5):1206-11.
    View in: PubMed
    Score: 0.074
  18. Community-level predictors of pneumococcal carriage and resistance in young children. Am J Epidemiol. 2004 Apr 01; 159(7):645-54.
    View in: PubMed
    Score: 0.071
  19. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003 Oct; 112(4):862-9.
    View in: PubMed
    Score: 0.069
  20. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010 Dec 16; 29(2):283-8.
    View in: PubMed
    Score: 0.028
  21. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics. 2010 Jun; 2(2):80-4.
    View in: PubMed
    Score: 0.027
  22. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine. 2010 Jul 05; 28(30):4842-6.
    View in: PubMed
    Score: 0.027
  23. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Jun; 26(6):468-72.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.